Characteristics | Study A (N = 160) | Study B (N = 157) | SENRI trial (N = 344) | Overall (N = 661) |
---|---|---|---|---|
 | n (%) | n (%) | n (%) | n (%) |
Age | ||||
  <  65 years | 89 (55.6) | 92 (58.6) | 160 (46.5) | 341 (51.6) |
  ≥ 65 years | 71 (44.4) | 65 (41.4) | 184 (53.5) | 320 (48.4) |
Sex | ||||
 Male | 92 (57.5) | 88 (56.1) | 211 (61.3) | 391 (59.2) |
 Female | 68 (42.5) | 69 (43.9) | 133 (38.7) | 270 (40.8) |
Motion sickness | ||||
 No | 143 (89.4) | 135 (86.0) | 282 (82.0) | 560 (84.7) |
 Yes | 17 (10.6) | 22 (14.0) | 56 (16.3) | 95 (14.4) |
 Unknown | 0 (0.0) | 0 (0.0) | 6 (1.7) | 6 (0.9) |
Drinking habit | ||||
 No | 126 (78.8) | 78 (49.7) | 245 (71.2) | 449 (67.9) |
 Yes | 34 (21.3) | 79 (50.3) | 93 (27.0) | 206 (31.2) |
 Unknown | 0 (0.0) | 0 (0.0) | 6 (1.7) | 6 (0.9) |
Regimen | ||||
 FOLFOX | 97 (60.6) | 79 (50.3) | 83 (24.1) | 259 (39.2) |
 XELOX | 63 (39.4) | 78 (49.7) | 261 (75.9) | 402 (60.8) |
Antiemetics | ||||
 2 | 114 (71.3) | 157 (100.0) | 170 (49.4) | 441 (66.7) |
 3 | 46 (28.8) | 0 (0.0) | 174 (50.6) | 220 (33.3) |